Seth Yakatan
Director/Board Member chez FITLIFE BRANDS, INC.
Profil
Seth Yakatan is the founder of Katan Associates International (founded in 2001), Kalytera Therapeutics, Inc. (founded in 2014), and Claritas Pharmaceuticals, Inc. (founded in 2004).
He holds the title of Partner at Katan Associates International since its founding.
Mr. Yakatan's current jobs include Director at DCI USA, Inc. (since 2005) and Independent Director at FitLife Brands, Inc. (since 2015).
His former jobs include Chief Financial Officer & Director at iSatori, Inc. (2014-2015) and Vice President-Business Development at Invion Ltd.
(2012-2017).
Mr. Yakatan received an MBA from the University of California, Irvine and an undergraduate degree from the University of Denver.
Postes actifs de Seth Yakatan
| Sociétés | Poste | Début |
|---|---|---|
| FITLIFE BRANDS, INC. | Director/Board Member | 01/09/2015 |
DCI USA, Inc.
 DCI USA, Inc. Real Estate DevelopmentFinance DCI USA, Inc. owns and operates income-producing real estate, and makes investments in and provides consulting services to other businesses. The company was founded on June 21, 2000 and is headquartered in Brooklyn, NY. | Director/Board Member | 01/02/2005 |
Katan Associates International
 Katan Associates International Katan Associates International operates as a corporate strategy and finance advisory group which focuses on the global life sciences industry. Its services include consulting, mergers and acquisitions,partnering, and merchant banking. The company was founded by Seth Yakatan and Stanley Yakatan in 2001 and is headquartered in Manhattan Beach, CA. | Founder | 01/04/2001 |
Anciens postes connus de Seth Yakatan
| Sociétés | Poste | Fin |
|---|---|---|
| CLARITAS PHARMACEUTICALS, INC. | Founder | 03/08/2017 |
| INVION LIMITED | Corporate Officer/Principal | 01/01/2017 |
| ISATORI INC | Director of Finance/CFO | 30/09/2015 |
Kalytera Therapeutics, Inc. /Old/
 Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Founder | - |
Formation de Seth Yakatan
| University of California, Irvine | Masters Business Admin |
| University of Denver | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| FITLIFE BRANDS, INC. | Health Technology |
| INVION LIMITED | Health Technology |
| CLARITAS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
DCI USA, Inc.
DCI USA, Inc. Real Estate DevelopmentFinance DCI USA, Inc. owns and operates income-producing real estate, and makes investments in and provides consulting services to other businesses. The company was founded on June 21, 2000 and is headquartered in Brooklyn, NY. | Finance |
Katan Associates International
Katan Associates International Katan Associates International operates as a corporate strategy and finance advisory group which focuses on the global life sciences industry. Its services include consulting, mergers and acquisitions,partnering, and merchant banking. The company was founded by Seth Yakatan and Stanley Yakatan in 2001 and is headquartered in Manhattan Beach, CA. | |
iSatori, Inc.
 iSatori, Inc. Pharmaceuticals: OtherHealth Technology iSatori, Inc. engages in the market, sale, and distribution of nutritional and dietary supplement products. It offers products through online, catalogs and various retail stores. The company was founded by Stephen D. Adelé in 2001 and is headquartered in Omaha, NE. | Health Technology |
Kalytera Therapeutics, Inc. /Old/
Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
